Mario Santiago
Concepts (357)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Friend murine leukemia virus | 16 | 2019 | 28 | 7.260 |
Why?
| Cytidine Deaminase | 20 | 2018 | 62 | 6.740 |
Why?
| Retroviridae Infections | 19 | 2020 | 47 | 6.160 |
Why?
| HIV-1 | 24 | 2020 | 698 | 3.480 |
Why?
| Virus Replication | 18 | 2020 | 406 | 3.120 |
Why?
| Antibodies, Neutralizing | 6 | 2017 | 118 | 2.880 |
Why?
| Simian Immunodeficiency Virus | 20 | 2015 | 60 | 2.710 |
Why?
| Interferon-alpha | 7 | 2020 | 201 | 2.490 |
Why?
| Simian Acquired Immunodeficiency Syndrome | 11 | 2015 | 58 | 2.200 |
Why?
| Antibodies, Viral | 9 | 2017 | 411 | 2.110 |
Why?
| Antigens, CD | 5 | 2016 | 556 | 1.990 |
Why?
| HIV Infections | 16 | 2020 | 1963 | 1.920 |
Why?
| Tumor Virus Infections | 7 | 2014 | 70 | 1.890 |
Why?
| Antiviral Agents | 8 | 2020 | 553 | 1.860 |
Why?
| Dendritic Cells | 5 | 2020 | 448 | 1.820 |
Why?
| Immunity, Innate | 10 | 2020 | 680 | 1.520 |
Why?
| Membrane Glycoproteins | 3 | 2016 | 516 | 1.450 |
Why?
| Somatic Hypermutation, Immunoglobulin | 2 | 2015 | 20 | 1.260 |
Why?
| Pan troglodytes | 11 | 2009 | 50 | 1.250 |
Why?
| Interferon Type I | 6 | 2020 | 124 | 1.230 |
Why?
| CD4-Positive T-Lymphocytes | 8 | 2017 | 977 | 1.010 |
Why?
| Interferon-beta | 2 | 2020 | 92 | 0.960 |
Why?
| Gastrointestinal Tract | 2 | 2020 | 148 | 0.950 |
Why?
| Virion | 4 | 2016 | 76 | 0.900 |
Why?
| Animals | 56 | 2020 | 33663 | 0.840 |
Why?
| Killer Cells, Natural | 5 | 2016 | 382 | 0.820 |
Why?
| Leukemia, Experimental | 4 | 2014 | 30 | 0.810 |
Why?
| Mice, Inbred BALB C | 9 | 2019 | 1232 | 0.790 |
Why?
| Proteins | 5 | 2018 | 977 | 0.780 |
Why?
| Mice, Knockout | 11 | 2019 | 2739 | 0.760 |
Why?
| Enterobacteriaceae | 1 | 2017 | 37 | 0.730 |
Why?
| Mice | 23 | 2020 | 14439 | 0.720 |
Why?
| Adaptive Immunity | 2 | 2019 | 157 | 0.700 |
Why?
| CD8-Positive T-Lymphocytes | 6 | 2019 | 587 | 0.690 |
Why?
| Viral Load | 8 | 2020 | 396 | 0.690 |
Why?
| RNA, Viral | 8 | 2016 | 543 | 0.680 |
Why?
| Immunity, Cellular | 2 | 2016 | 296 | 0.660 |
Why?
| Immunoglobulin Heavy Chains | 1 | 2015 | 65 | 0.650 |
Why?
| Feces | 10 | 2017 | 352 | 0.640 |
Why?
| B-Lymphocytes | 4 | 2017 | 895 | 0.640 |
Why?
| Immunoglobulin Variable Region | 1 | 2015 | 72 | 0.640 |
Why?
| Immunomodulation | 1 | 2016 | 79 | 0.640 |
Why?
| Host-Pathogen Interactions | 3 | 2020 | 267 | 0.630 |
Why?
| Immunoglobulin Fc Fragments | 1 | 2015 | 31 | 0.620 |
Why?
| Mice, Inbred C57BL | 14 | 2019 | 4890 | 0.610 |
Why?
| Viremia | 6 | 2020 | 107 | 0.610 |
Why?
| Intestines | 1 | 2017 | 292 | 0.590 |
Why?
| Endoribonucleases | 1 | 2013 | 68 | 0.550 |
Why?
| Endogenous Retroviruses | 1 | 2012 | 11 | 0.520 |
Why?
| Antibody Formation | 3 | 2017 | 292 | 0.520 |
Why?
| Antibody Affinity | 1 | 2010 | 54 | 0.460 |
Why?
| Molecular Sequence Data | 16 | 2014 | 3485 | 0.440 |
Why?
| Signal Transduction | 5 | 2020 | 4768 | 0.440 |
Why?
| Intestinal Mucosa | 4 | 2019 | 501 | 0.440 |
Why?
| Antigens, Helminth | 2 | 1999 | 21 | 0.440 |
Why?
| Cercocebus atys | 3 | 2006 | 5 | 0.430 |
Why?
| Schistosomiasis japonica | 2 | 1999 | 20 | 0.430 |
Why?
| Spleen | 5 | 2018 | 561 | 0.430 |
Why?
| HIV-2 | 3 | 2006 | 16 | 0.430 |
Why?
| Receptor, Interferon alpha-beta | 2 | 2020 | 22 | 0.410 |
Why?
| Animals, Wild | 3 | 2005 | 44 | 0.410 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 1163 | 0.400 |
Why?
| Ape Diseases | 3 | 2008 | 5 | 0.390 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2016 | 1929 | 0.390 |
Why?
| Disease Reservoirs | 2 | 2006 | 17 | 0.380 |
Why?
| Base Sequence | 7 | 2015 | 2463 | 0.380 |
Why?
| Cells, Cultured | 10 | 2018 | 4283 | 0.370 |
Why?
| Retroviridae | 2 | 2018 | 97 | 0.370 |
Why?
| Lymphocyte Activation | 5 | 2017 | 1191 | 0.370 |
Why?
| Colon | 2 | 2019 | 177 | 0.370 |
Why?
| Macaca mulatta | 4 | 2015 | 126 | 0.350 |
Why?
| Flow Cytometry | 4 | 2017 | 1167 | 0.350 |
Why?
| Immunity, Mucosal | 3 | 2020 | 85 | 0.350 |
Why?
| Virus Diseases | 2 | 2018 | 168 | 0.340 |
Why?
| Sequence Analysis, DNA | 5 | 2017 | 797 | 0.330 |
Why?
| Humans | 48 | 2020 | 99981 | 0.320 |
Why?
| Gene Expression Profiling | 5 | 2020 | 1523 | 0.320 |
Why?
| Dysbiosis | 2 | 2017 | 90 | 0.320 |
Why?
| Viral Regulatory and Accessory Proteins | 3 | 2016 | 18 | 0.320 |
Why?
| Phylogeny | 13 | 2017 | 763 | 0.310 |
Why?
| Genetic Variation | 4 | 2015 | 921 | 0.310 |
Why?
| Cercopithecus | 1 | 2003 | 2 | 0.300 |
Why?
| Disease Models, Animal | 5 | 2018 | 3684 | 0.300 |
Why?
| Bone Marrow Cells | 3 | 2016 | 291 | 0.300 |
Why?
| Interferon-gamma | 2 | 2019 | 768 | 0.290 |
Why?
| NF-kappa B | 2 | 2018 | 680 | 0.270 |
Why?
| Antibodies, Helminth | 2 | 1999 | 14 | 0.270 |
Why?
| Immunoglobulin G | 3 | 2016 | 761 | 0.260 |
Why?
| Recombination, Genetic | 4 | 2015 | 189 | 0.260 |
Why?
| Genome, Viral | 1 | 2003 | 129 | 0.260 |
Why?
| Acute Disease | 2 | 2016 | 958 | 0.250 |
Why?
| Bacterial Translocation | 2 | 2019 | 37 | 0.230 |
Why?
| Evolution, Molecular | 3 | 2016 | 442 | 0.230 |
Why?
| Interferon-Induced Helicase, IFIH1 | 1 | 2020 | 13 | 0.230 |
Why?
| Picornaviridae | 1 | 2020 | 18 | 0.230 |
Why?
| Tropomyosin | 1 | 1999 | 37 | 0.220 |
Why?
| Immunologic Factors | 2 | 2019 | 197 | 0.220 |
Why?
| Sialic Acid Binding Ig-like Lectin 1 | 1 | 2018 | 1 | 0.210 |
Why?
| GPI-Linked Proteins | 2 | 2016 | 53 | 0.210 |
Why?
| nef Gene Products, Human Immunodeficiency Virus | 3 | 2016 | 21 | 0.210 |
Why?
| Keratinocytes | 2 | 2018 | 211 | 0.210 |
Why?
| Helminth Proteins | 1 | 1999 | 27 | 0.210 |
Why?
| Gram-Positive Bacteria | 1 | 2019 | 49 | 0.210 |
Why?
| Lectins | 1 | 2018 | 53 | 0.210 |
Why?
| Sexually Transmitted Diseases, Viral | 1 | 1998 | 4 | 0.210 |
Why?
| Protective Agents | 1 | 2018 | 40 | 0.200 |
Why?
| Gram-Negative Bacteria | 1 | 2019 | 69 | 0.200 |
Why?
| SAM Domain and HD Domain-Containing Protein 1 | 1 | 2018 | 2 | 0.200 |
Why?
| Papillomavirus E7 Proteins | 1 | 2018 | 8 | 0.200 |
Why?
| Lymph Nodes | 3 | 2018 | 455 | 0.200 |
Why?
| Genotype | 3 | 2013 | 2022 | 0.200 |
Why?
| Cullin Proteins | 1 | 2018 | 10 | 0.200 |
Why?
| Human papillomavirus 16 | 1 | 2018 | 28 | 0.200 |
Why?
| Biological Products | 1 | 2019 | 100 | 0.200 |
Why?
| T-Lymphocytes, Cytotoxic | 2 | 2018 | 168 | 0.200 |
Why?
| HIV | 3 | 2018 | 163 | 0.200 |
Why?
| Human Immunodeficiency Virus Proteins | 2 | 2016 | 2 | 0.190 |
Why?
| Immunoglobulin M | 2 | 2017 | 254 | 0.190 |
Why?
| APOBEC-1 Deaminase | 2 | 2014 | 4 | 0.190 |
Why?
| Peripheral Tolerance | 1 | 2017 | 6 | 0.190 |
Why?
| HIV Seropositivity | 1 | 1998 | 103 | 0.190 |
Why?
| Viral Tropism | 1 | 2017 | 28 | 0.190 |
Why?
| Proteolysis | 1 | 2018 | 130 | 0.190 |
Why?
| Lymphocytes | 1 | 2019 | 365 | 0.190 |
Why?
| Male | 19 | 2020 | 56936 | 0.180 |
Why?
| Gastrointestinal Microbiome | 2 | 2019 | 320 | 0.180 |
Why?
| Interleukins | 1 | 2019 | 212 | 0.180 |
Why?
| Butyrates | 1 | 2017 | 33 | 0.180 |
Why?
| Immunoglobulin E | 1 | 1999 | 317 | 0.180 |
Why?
| Parvoviridae Infections | 1 | 2016 | 11 | 0.180 |
Why?
| Disease Resistance | 1 | 2016 | 20 | 0.180 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 2017 | 124 | 0.180 |
Why?
| Toll-Like Receptor 7 | 1 | 2016 | 40 | 0.180 |
Why?
| Female | 20 | 2020 | 57853 | 0.180 |
Why?
| Mutagenesis, Insertional | 1 | 2016 | 66 | 0.180 |
Why?
| Interleukin-12 | 1 | 2016 | 105 | 0.170 |
Why?
| Lymphoid Tissue | 2 | 2020 | 48 | 0.170 |
Why?
| Primates | 2 | 2015 | 99 | 0.170 |
Why?
| Papillomavirus Infections | 1 | 2018 | 176 | 0.170 |
Why?
| Interleukin-15 | 1 | 2016 | 64 | 0.170 |
Why?
| NIH 3T3 Cells | 1 | 2016 | 117 | 0.170 |
Why?
| Phenotype | 2 | 2016 | 2751 | 0.170 |
Why?
| B7-1 Antigen | 1 | 2016 | 72 | 0.170 |
Why?
| Gene Products, nef | 2 | 2006 | 14 | 0.170 |
Why?
| Antibody Diversity | 1 | 2015 | 15 | 0.170 |
Why?
| Amino Acid Sequence | 7 | 2016 | 2518 | 0.170 |
Why?
| PTEN Phosphohydrolase | 1 | 2017 | 151 | 0.160 |
Why?
| Cell Line | 5 | 2014 | 2868 | 0.160 |
Why?
| Colobus | 1 | 2014 | 2 | 0.160 |
Why?
| Major Histocompatibility Complex | 1 | 2016 | 184 | 0.160 |
Why?
| Toll-Like Receptor 3 | 1 | 2014 | 36 | 0.160 |
Why?
| Endocytosis | 1 | 2016 | 151 | 0.160 |
Why?
| Interleukin-2 | 1 | 2016 | 378 | 0.150 |
Why?
| Prevalence | 4 | 2006 | 2159 | 0.150 |
Why?
| Cote d'Ivoire | 2 | 2005 | 6 | 0.150 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2017 | 314 | 0.150 |
Why?
| Germinal Center | 1 | 2014 | 56 | 0.150 |
Why?
| Antigen Presentation | 1 | 2016 | 209 | 0.150 |
Why?
| Cell Proliferation | 2 | 2019 | 2240 | 0.150 |
Why?
| env Gene Products, Human Immunodeficiency Virus | 1 | 2013 | 14 | 0.150 |
Why?
| Papillomaviridae | 1 | 2014 | 119 | 0.150 |
Why?
| Cloning, Molecular | 3 | 2013 | 619 | 0.150 |
Why?
| Virus Integration | 1 | 2013 | 43 | 0.150 |
Why?
| Gene Frequency | 1 | 2015 | 555 | 0.140 |
Why?
| Biological Evolution | 2 | 2012 | 425 | 0.140 |
Why?
| Transcriptome | 1 | 2017 | 436 | 0.140 |
Why?
| Amino Acids | 1 | 2016 | 409 | 0.140 |
Why?
| DNA Damage | 1 | 2015 | 339 | 0.140 |
Why?
| Tanzania | 2 | 2003 | 58 | 0.140 |
Why?
| Uganda | 2 | 2003 | 64 | 0.140 |
Why?
| Case-Control Studies | 1 | 2020 | 3137 | 0.130 |
Why?
| T-Lymphocyte Subsets | 1 | 2016 | 447 | 0.130 |
Why?
| Inbreeding | 1 | 2012 | 20 | 0.130 |
Why?
| Retroviridae Proteins | 2 | 2003 | 13 | 0.130 |
Why?
| Immunity, Humoral | 1 | 2013 | 83 | 0.130 |
Why?
| Urine | 2 | 2003 | 70 | 0.130 |
Why?
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 398 | 0.130 |
Why?
| Reverse Transcription | 1 | 2011 | 12 | 0.130 |
Why?
| Adult | 9 | 2020 | 29332 | 0.130 |
Why?
| Neutralization Tests | 2 | 2008 | 71 | 0.130 |
Why?
| HEK293 Cells | 3 | 2019 | 592 | 0.130 |
Why?
| Cell Membrane | 1 | 2016 | 767 | 0.120 |
Why?
| Philippines | 3 | 2001 | 53 | 0.120 |
Why?
| Mice, Inbred Strains | 1 | 2012 | 456 | 0.120 |
Why?
| B-Cell Activation Factor Receptor | 1 | 2010 | 15 | 0.120 |
Why?
| Young Adult | 4 | 2020 | 9815 | 0.120 |
Why?
| Down-Regulation | 3 | 2018 | 689 | 0.120 |
Why?
| vif Gene Products, Human Immunodeficiency Virus | 1 | 2010 | 4 | 0.120 |
Why?
| Leukemia Virus, Murine | 1 | 2010 | 16 | 0.120 |
Why?
| Phenylacetates | 1 | 2010 | 11 | 0.120 |
Why?
| CD4 Antigens | 3 | 2006 | 132 | 0.120 |
Why?
| Cytosine Deaminase | 1 | 2010 | 12 | 0.120 |
Why?
| Nitrophenols | 1 | 2010 | 27 | 0.120 |
Why?
| Gene Products, gag | 1 | 2010 | 37 | 0.120 |
Why?
| DNA Primers | 3 | 2013 | 638 | 0.120 |
Why?
| Middle Aged | 7 | 2020 | 26943 | 0.120 |
Why?
| Bacteria | 1 | 2017 | 636 | 0.110 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 2016 | 916 | 0.110 |
Why?
| Escherichia coli | 1 | 2014 | 790 | 0.110 |
Why?
| Lentivirus | 2 | 2013 | 55 | 0.110 |
Why?
| Gene Expression Regulation | 3 | 2018 | 2531 | 0.110 |
Why?
| Plasma | 1 | 2011 | 214 | 0.110 |
Why?
| Sequence Analysis, RNA | 1 | 2011 | 299 | 0.110 |
Why?
| Molecular Epidemiology | 2 | 2006 | 58 | 0.100 |
Why?
| Simian foamy virus | 1 | 2008 | 2 | 0.100 |
Why?
| Cross-Sectional Studies | 4 | 2018 | 3441 | 0.100 |
Why?
| Sequence Homology, Amino Acid | 3 | 2011 | 440 | 0.100 |
Why?
| Immunization | 1 | 2010 | 343 | 0.090 |
Why?
| Apoptosis | 3 | 2014 | 2524 | 0.090 |
Why?
| Inflammation | 1 | 2018 | 2071 | 0.090 |
Why?
| Mutation | 2 | 2014 | 3144 | 0.090 |
Why?
| Lentiviruses, Primate | 1 | 2006 | 5 | 0.090 |
Why?
| Chromosome Mapping | 1 | 2008 | 621 | 0.090 |
Why?
| Genes, env | 1 | 2005 | 4 | 0.090 |
Why?
| Genes, gag | 1 | 2005 | 4 | 0.090 |
Why?
| Promoter Regions, Genetic | 1 | 2011 | 1258 | 0.090 |
Why?
| Social Dominance | 1 | 2005 | 14 | 0.080 |
Why?
| Disease Transmission, Infectious | 1 | 2005 | 67 | 0.080 |
Why?
| Infectious Disease Transmission, Vertical | 1 | 2005 | 103 | 0.080 |
Why?
| Blotting, Western | 3 | 2010 | 1399 | 0.080 |
Why?
| Poliovirus Vaccine, Oral | 1 | 2004 | 20 | 0.080 |
Why?
| Dependovirus | 2 | 2016 | 36 | 0.080 |
Why?
| T-Lymphocytes | 2 | 2016 | 1609 | 0.070 |
Why?
| Macrophages | 3 | 2018 | 1106 | 0.070 |
Why?
| Endemic Diseases | 1 | 2003 | 38 | 0.070 |
Why?
| Disease Outbreaks | 1 | 2006 | 279 | 0.070 |
Why?
| Cell Survival | 2 | 2019 | 1095 | 0.070 |
Why?
| Acquired Immunodeficiency Syndrome | 1 | 2004 | 185 | 0.070 |
Why?
| Neoplasms | 1 | 2015 | 1861 | 0.070 |
Why?
| DNA, Viral | 2 | 2010 | 459 | 0.070 |
Why?
| Recombinant Proteins | 2 | 2018 | 1443 | 0.070 |
Why?
| Mice, Transgenic | 2 | 2020 | 2117 | 0.060 |
Why?
| Time Factors | 1 | 2014 | 7088 | 0.060 |
Why?
| Wuchereria bancrofti | 1 | 2001 | 3 | 0.060 |
Why?
| Filariasis | 1 | 2001 | 6 | 0.060 |
Why?
| DNA, Helminth | 1 | 2001 | 19 | 0.060 |
Why?
| Polymerase Chain Reaction | 2 | 2002 | 1156 | 0.060 |
Why?
| Immunoblotting | 1 | 2002 | 394 | 0.060 |
Why?
| Leukocytes, Mononuclear | 2 | 2018 | 471 | 0.060 |
Why?
| Protein Structure, Tertiary | 2 | 2014 | 945 | 0.060 |
Why?
| Virus Assembly | 1 | 2001 | 73 | 0.060 |
Why?
| Protein-Serine-Threonine Kinases | 1 | 2004 | 597 | 0.060 |
Why?
| Immune Evasion | 1 | 2020 | 40 | 0.060 |
Why?
| Snails | 1 | 1999 | 38 | 0.050 |
Why?
| Gene Library | 1 | 1999 | 120 | 0.050 |
Why?
| Erythroblasts | 1 | 2018 | 6 | 0.050 |
Why?
| Immunoglobulin A | 1 | 1999 | 139 | 0.050 |
Why?
| CD4 Lymphocyte Count | 2 | 2014 | 251 | 0.050 |
Why?
| Nucleic Acid Heteroduplexes | 1 | 1998 | 12 | 0.050 |
Why?
| Interferon Regulatory Factor-7 | 1 | 2018 | 6 | 0.050 |
Why?
| Sendai virus | 1 | 2018 | 6 | 0.050 |
Why?
| Sex Work | 1 | 1998 | 17 | 0.050 |
Why?
| NF-KappaB Inhibitor alpha | 1 | 2018 | 58 | 0.050 |
Why?
| THP-1 Cells | 1 | 2018 | 19 | 0.050 |
Why?
| Recombinant Fusion Proteins | 2 | 2016 | 693 | 0.050 |
Why?
| Rabbits | 1 | 1999 | 772 | 0.050 |
Why?
| I-kappa B Kinase | 1 | 2018 | 51 | 0.050 |
Why?
| Protein Isoforms | 1 | 2019 | 361 | 0.050 |
Why?
| Enzyme Stability | 1 | 2018 | 101 | 0.050 |
Why?
| Disease Progression | 2 | 2016 | 2292 | 0.050 |
Why?
| Sensitivity and Specificity | 1 | 2003 | 1886 | 0.050 |
Why?
| Antigenic Variation | 1 | 1997 | 9 | 0.050 |
Why?
| Cell Line, Transformed | 1 | 2018 | 170 | 0.050 |
Why?
| Antigens, Protozoan | 1 | 1997 | 20 | 0.050 |
Why?
| Palatine Tonsil | 1 | 2017 | 28 | 0.050 |
Why?
| Anti-Retroviral Agents | 1 | 2019 | 155 | 0.050 |
Why?
| Plasmodium falciparum | 1 | 1997 | 34 | 0.050 |
Why?
| Gene Silencing | 1 | 2018 | 180 | 0.050 |
Why?
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2017 | 41 | 0.050 |
Why?
| Ki-67 Antigen | 1 | 2017 | 111 | 0.050 |
Why?
| Cross Reactions | 1 | 2017 | 154 | 0.050 |
Why?
| HIV Envelope Protein gp120 | 1 | 2017 | 81 | 0.050 |
Why?
| Malaria, Falciparum | 1 | 1997 | 40 | 0.050 |
Why?
| Antigens, Surface | 1 | 1997 | 151 | 0.050 |
Why?
| DNA, Ribosomal | 1 | 2017 | 85 | 0.050 |
Why?
| Protozoan Proteins | 1 | 1997 | 70 | 0.050 |
Why?
| Receptors, CXCR4 | 1 | 2017 | 74 | 0.050 |
Why?
| APOBEC-3G Deaminase | 1 | 2016 | 6 | 0.040 |
Why?
| Myxovirus Resistance Proteins | 1 | 2016 | 9 | 0.040 |
Why?
| Interleukin-1beta | 1 | 2019 | 387 | 0.040 |
Why?
| DNA, Mitochondrial | 2 | 2008 | 168 | 0.040 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2016 | 108 | 0.040 |
Why?
| Amino Acid Motifs | 1 | 2016 | 213 | 0.040 |
Why?
| Sequence Deletion | 1 | 2016 | 210 | 0.040 |
Why?
| Models, Biological | 1 | 2004 | 1786 | 0.040 |
Why?
| Immunotherapy | 1 | 2019 | 374 | 0.040 |
Why?
| Vaccines | 1 | 1999 | 232 | 0.040 |
Why?
| Receptors, Antigen, B-Cell | 1 | 2017 | 219 | 0.040 |
Why?
| Cluster Analysis | 1 | 2017 | 451 | 0.040 |
Why?
| DNA, Bacterial | 1 | 2017 | 310 | 0.040 |
Why?
| Receptors, CXCR5 | 1 | 2014 | 11 | 0.040 |
Why?
| Receptors, CCR7 | 1 | 2014 | 23 | 0.040 |
Why?
| Imidazoles | 1 | 2016 | 240 | 0.040 |
Why?
| Protein Processing, Post-Translational | 1 | 2018 | 441 | 0.040 |
Why?
| Cervix Uteri | 1 | 2014 | 45 | 0.040 |
Why?
| Protein Transport | 1 | 2016 | 430 | 0.040 |
Why?
| RNA, Ribosomal, 16S | 1 | 2017 | 440 | 0.040 |
Why?
| Biopsy | 1 | 2018 | 1037 | 0.040 |
Why?
| Antigens, Viral | 1 | 2014 | 153 | 0.040 |
Why?
| Sexual Behavior | 1 | 1998 | 379 | 0.040 |
Why?
| Viral Proteins | 1 | 2016 | 336 | 0.040 |
Why?
| Caspase 1 | 1 | 2014 | 145 | 0.040 |
Why?
| Genetic Engineering | 1 | 2013 | 84 | 0.030 |
Why?
| Mucous Membrane | 1 | 2014 | 112 | 0.030 |
Why?
| Phosphorylation | 1 | 2018 | 1758 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 332 | 0.030 |
Why?
| Sequence Alignment | 1 | 2013 | 390 | 0.030 |
Why?
| Retroelements | 1 | 2011 | 34 | 0.030 |
Why?
| Microbiota | 1 | 2017 | 439 | 0.030 |
Why?
| Cytokines | 1 | 2019 | 1820 | 0.030 |
Why?
| In Vitro Techniques | 1 | 2014 | 1294 | 0.030 |
Why?
| HeLa Cells | 2 | 2005 | 617 | 0.030 |
Why?
| Child | 2 | 2017 | 14886 | 0.030 |
Why?
| HIV Reverse Transcriptase | 1 | 2010 | 27 | 0.030 |
Why?
| Glycosylation | 1 | 2010 | 122 | 0.030 |
Why?
| Aged | 2 | 2017 | 18414 | 0.030 |
Why?
| HIV Core Protein p24 | 1 | 2009 | 30 | 0.030 |
Why?
| L-Selectin | 1 | 2009 | 26 | 0.030 |
Why?
| Cell Movement | 1 | 2014 | 872 | 0.030 |
Why?
| Autoantibodies | 1 | 2017 | 1095 | 0.030 |
Why?
| DNA Replication | 1 | 2010 | 191 | 0.030 |
Why?
| Infant, Newborn | 1 | 1999 | 4572 | 0.030 |
Why?
| Africa, Central | 1 | 2008 | 3 | 0.030 |
Why?
| Genetics, Microbial | 1 | 2008 | 10 | 0.030 |
Why?
| Alternative Splicing | 1 | 2010 | 197 | 0.030 |
Why?
| HLA-DR Antigens | 1 | 2009 | 223 | 0.030 |
Why?
| Adolescent | 2 | 2012 | 16942 | 0.020 |
Why?
| Aged, 80 and over | 1 | 1999 | 6416 | 0.020 |
Why?
| Gene Products, pol | 1 | 2007 | 7 | 0.020 |
Why?
| Ecology | 1 | 2008 | 89 | 0.020 |
Why?
| Prospective Studies | 1 | 1998 | 5387 | 0.020 |
Why?
| Consensus Sequence | 1 | 2007 | 81 | 0.020 |
Why?
| Infant | 1 | 1999 | 7362 | 0.020 |
Why?
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2006 | 9 | 0.020 |
Why?
| Cameroon | 1 | 2006 | 8 | 0.020 |
Why?
| HIV Antibodies | 1 | 2006 | 43 | 0.020 |
Why?
| Child, Preschool | 1 | 1999 | 8831 | 0.020 |
Why?
| p21-Activated Kinases | 1 | 2004 | 12 | 0.020 |
Why?
| Africa, Western | 1 | 2004 | 13 | 0.020 |
Why?
| Risk Factors | 1 | 1998 | 8337 | 0.020 |
Why?
| CD28 Antigens | 1 | 2004 | 49 | 0.020 |
Why?
| Haplotypes | 1 | 2006 | 544 | 0.020 |
Why?
| Protein Binding | 1 | 2010 | 2102 | 0.020 |
Why?
| Mutagenesis, Site-Directed | 1 | 2005 | 423 | 0.020 |
Why?
| Ecosystem | 1 | 2008 | 466 | 0.020 |
Why?
| Green Fluorescent Proteins | 1 | 2005 | 416 | 0.020 |
Why?
| Histocompatibility Antigens Class II | 1 | 2004 | 354 | 0.020 |
Why?
| Transfection | 1 | 2005 | 1030 | 0.020 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 2001 | 24 | 0.020 |
Why?
| Africa | 1 | 2001 | 92 | 0.020 |
Why?
| Structure-Activity Relationship | 1 | 2001 | 583 | 0.010 |
Why?
| Malaria Vaccines | 1 | 1997 | 5 | 0.010 |
Why?
| DNA, Protozoan | 1 | 1997 | 30 | 0.010 |
Why?
| Cell Nucleus | 1 | 2001 | 585 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2004 | 2625 | 0.010 |
Why?
| Point Mutation | 1 | 1997 | 265 | 0.010 |
Why?
| Epitopes | 1 | 1997 | 398 | 0.010 |
Why?
|
|
Santiago's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|